ELISA | LAC | TP | aD1/aD4–5 | LIA |
---|
| ACL | aβ2GPI | Any aPL | aCL | aPA | aPC | aPE | aPG | aPI | aPS | aAnV | aβ2GPI | aPT | Any aPL |
---|
G | M | G | M | G | M | G | M | G | M | G | M | G | M | G | M | G | M | G | M | G | M | G | M |
---|
APS n = 34 | 24 | 21 | 30 | 18 | 31 | 24 | 14 | 28 | 27 | 13 | 24 | 10 | 0 | 0 | 0 | 0 | 18 | 1 | 7 | 2 | 30 | 16 | 2 | 5 | 27 | 17 | 17 | 5 | 33 |
SARD n = 41 | 18*** | 19 | 25** | 23 | 33 | 18*** | 8 | 26 | 26 | 12 | 22 | 8 | 0 | 0 | 0 | 0 | 4* | 0 | 3 | 2 | 27*** | 9*** | 0 | 3 | 22*** | 12 | 7** | 3 | 32 |
HS n = 20 | NA | 0# | 0# | 1## | 1# | NA | NA | NA | 1# | 0## | 0# | 0#### | 0 | 0 | 0 | 1 | 0# | 1 | 0#### | 0 | 0# | 0## | 0 | 0 | 1# | 0# | 1## | 1 | 3# |
- Comparison of APS vs SARD: *p < 0.001, **p < 0.01, ***p < 0.05
- Comparison of APS vs HC: #p < 0.0001, ##p < 0.001, ###p < 0.01, ####p < 0.05
- LAC and TP testing was conducted for 33 APS and 39 SARD patients only
- aβ2GPI anti-beta2 glycoprotein I, aCL anti-cardiolipin, aD1 anti-domain 1, aD4–5 anti-domains 4 and 5, aPA anti-phosphatidic acid, aPC anti-phosphatidylcholine, aPE anti-phosphatidylethanolamine, aPG anti-phosphatidylglycerol, aPI anti-phosphatidylinositol, aPS anti-phosphatidyl-serine, aAnV anti-annexin V, aPT anti-prothrombin, LAC lupus anti-coagulant, TP triple positivity (aCL positive, aβ2GPI positive, LAC positive), NA not available